HIGHLIGHTS
- who: Naoya Murakami et al. from the Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan have published the paper: Now is it time to implement spacers in cervical cancer brachytherapy?, in the Journal: (JOURNAL)
SUMMARY
Interstitial brachytherapy or the hybrid of intracavitary and interstitial brachytherapy (HBT) would offer help for meeting such strict dose constraints, particularly in the case of large or irregularly shaped tumors. The Japanese guidelines recommend using a central shield (CS) following 20-40 Gy of whole pelvic radiation therapy to avoid extremely high radiation exposure for the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.